Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13 ...

Understanding the biology of these bacteria—such as how they synthesize their protective capsules—is essential for developing new strategies to counter antibiotic resistance. Streptococcus pneumoniae ...

We describe our institutional experience with clinical response and microbiologic cure rates of infections caused by ESBL-producing gram-negative bacteria when treated with ertapenem as a first ...

MBL-producing Gram-negative bacteria are among the most challenging infections to control, are on the rise globally, and are a priority pathogen for the World Health Organization (WHO).

MBL-producing Gram-negative bacteria are on the rise globally and are a priority pathogen for the World Health Organization (WHO), which has said they are an emerging threat. The new drug's label ...

aureus, vancomycin-resistant enterococci, extended spectrum β-lactamase-producing Gram-negative bacteria, multidrug-resistant M. tuberculosisaccording to some studies, and, importantly ...

Understanding the biology of these bacteria—such as how they synthesize their protective capsules—is essential for developing new strategies to counter antibiotic resistance. Streptococcus ...